换一批
换一批Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
作者：
主题词
成年人(Adult);老年人(Aged);癌, 肝细胞(Carcinoma, Hepatocellular);导管消融术(Catheter Ablation);欧洲(Europe);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);发病率(Incidence);意图(Intention);肝肿瘤(Liver Neoplasms);肝移植(Liver Transplantation);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);手术后并发症(Postoperative Complications);预后(Prognosis);前瞻性研究(Prospective Studies);回顾性研究(Retrospective Studies);危险因素(Risk Factors);存活率(Survival Rate);美国(United States);青年人(Young Adult);甲胎蛋白类(alpha-Fetoproteins)
DOI
10.1245/s10434-014-4273-6
PMID
25472651
发布时间
2022-03-10
- 浏览21
Annals of surgical oncology
2286-94页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
